Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma

In conclusion, ccfDNA-related BMs are frequently detected in ACC patients and represent a promising, minimally invasive tool to predict clinical outcome and complement surveillance imaging. Our findings will be validated in a larger cohort of ACCs with long-term follow-up.PMID:38451242 | DOI:10.1093/ejendo/lvae022

Source: European Journal of Endocrinology - March 7, 2024 Category: Endocrinology Authors: Juliane Lippert Gabrielle Smith Silke Appenzeller Laura-Sophie Landwehr Alessandro Prete Sonja Steinhauer Miriam Asia Hanna Urlaub Yasir S Elhassan Stefan Kircher Wiebke Arlt Martin Fassnacht Barbara Altieri Cristina L Ronchi Source Type: research